effect of Triphaladi Granules on Diabetes

Phase 1

Completed

Conditions: Health Condition 1: null- Patients suffering from Prameha ( Diabetes Mellitus )

Registration Number: CTRI/2011/12/002195

Lead Sponsor: IPGTRA Gujarat Ayurved University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 50

Inclusion Criteria

Known patient of Type II Diabetes mellitus, and also the patients preliminarily diagnosed Type II Diabetes mellitus on the basis of signs and symptoms of the disease will be confirmed by FBS and PPBS and then will be included in study.

Patients presenting with Type2 DM having ,

Random serum glucose level of greater than 200 mg/dl.

Fasting Blood Sugar greater than 126 mg/dl

Patients of Type2 Diabetes mellitus under Modern medication.

Exclusion Criteria

1. Age below 30 years & above 70 years.

2.Patients of Sahaja Prameha and having bala and dhatukshaya (gestational diabetes mellitus) and Type I Diabetes mellitus.

3.Patient having any one of following condition.

•Malignant and accelerated hypertensive

•CVS disorder (CAD)

•Pregnant woman and planning to be pregnant within six months

•Lactating mother

•Secondary Diabetes mellitus,Diabetic ketosis

•CNS disorder e.g. encephalopathy

•Patient under going regular treatment for any other severe illness and also patients suffering from Tuberculosis, Carcinoma and HIV positive patients. will be excluded for the present study including endocrinal disorders like, Thyrotoxicosis, Cushing Syndrome etc.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The efficacy of treatment will be assessed on the basis of relief in signs and symptoms. <br/ ><br>Evaluation of biochemical parameters such as FBS, PPBS in both groups along with Hematological, Urine routine and microscopic examination before and after the treatment. S. Insulin and Glycosulated haemoglobin before and after the treatment.(if possible ) <br/ ><br>Timepoint: At interval of one month and of two months the Evaluation of biochemical parameters such as FBS, PPBS in both groups along with Hematological, Urine routine and microscopic examination before and after the treatment. S. Insulin and Glycosulated haemoglobin before and after the treatment.(if possible ) <br/ ><br>and The efficacy of treatment will be assessed on the basis of relief in signs and symptoms. <br/ ><br>

Secondary Outcome Measures